← FDA Warning Letters
Harbin Jixianglong Biotech Co., Ltd.
FDA Warning Letter · 2026-05-19 · Center for Drug Evaluation and Research (CDER)
Letter
- Company
- Harbin Jixianglong Biotech Co., Ltd.
- Posted Date
- 2026-05-19
- Letter Issue Date
- 2026-05-01
- Issuing Office
- Center for Drug Evaluation and Research (CDER)
Subject
CGMP/API/Adulterated and Misbranded Drugs
Source
- Authoritative
- FDA Warning Letters
- Machine
- JSON-LD · Markdown